D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 30,120 183 World Ranking 14872 National Ranking 7643

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Breast cancer

Her primary scientific interests are in Breast cancer, Internal medicine, Gynecology, Relative risk and Oncology. The various areas that Catherine Schairer examines in her Breast cancer study include Menopause, Estrogen, Risk factor and Obstetrics. Many of her studies involve connections with topics such as Endocrinology and Internal medicine.

Her research investigates the connection between Gynecology and topics such as Lower risk that intersect with problems in Smoking cessation. Her studies deal with areas such as Attributable risk, Absolute risk reduction and Breast biopsy as well as Relative risk. Her Oncology research is multidisciplinary, incorporating perspectives in Endometrial cancer and Adenocarcinoma.

Her most cited work include:

  • Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually (2604 citations)
  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (2099 citations)
  • ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA (1069 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer and Gynecology. Her work in Internal medicine is not limited to one particular discipline; it also encompasses Endocrinology. The concepts of her Breast cancer study are interwoven with issues in Epidemiology, Relative risk, Obstetrics, Estrogen and Risk factor.

Her Relative risk research is multidisciplinary, incorporating elements of Attributable risk and Mammography. Her Oncology research also works with subjects such as

  • Odds ratio and related Dyslipidemia,
  • Regimen which is related to area like Rectum. Her Gynecology research includes themes of Hysterectomy, Case-control study, Menopause, Endometrial cancer and Hormone replacement therapy.

She most often published in these fields:

  • Internal medicine (64.67%)
  • Breast cancer (58.70%)
  • Oncology (36.41%)

What were the highlights of her more recent work (between 2016-2020)?

  • Internal medicine (64.67%)
  • Breast cancer (58.70%)
  • Oncology (36.41%)

In recent papers she was focusing on the following fields of study:

Catherine Schairer spends much of her time researching Internal medicine, Breast cancer, Oncology, Cancer and Odds ratio. Her Internal medicine research focuses on Diabetes mellitus and how it connects with Obesity. She works in the field of Breast cancer, focusing on Inflammatory breast cancer in particular.

The Oncology study which covers Meta-analysis that intersects with Body mass index, Epidemiology of cancer and Menopausal hormone therapy. She has researched Prospective cohort study in several fields, including Ovary, Ovarian cancer, Fallopian tube and Risk factor. Gynecology is closely connected to Etiology in her research, which is encompassed under the umbrella topic of Family history.

Between 2016 and 2020, her most popular works were:

  • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (122 citations)
  • Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. (51 citations)
  • Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. (45 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Breast cancer

Catherine Schairer mainly investigates Internal medicine, Oncology, Breast cancer, Epidemiology and Meta-analysis. Her study in Body mass index, Prospective cohort study, Odds ratio, Hepatocellular carcinoma and Cancer is done as part of Internal medicine. Her Body mass index study integrates concerns from other disciplines, such as Gallbladder cancer and Risk factor.

Her Prospective cohort study research focuses on subjects like Confidence interval, which are linked to Case-control study and Cohort study. Her research investigates the link between Oncology and topics such as Diabetes mellitus that cross with problems in Gynecology. Catherine Schairer combines subjects such as Overweight, Epidemiology of cancer, Menopausal hormone therapy, Aspirin and Endometrial cancer with her study of Epidemiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

Mitchell H. Gail;Louise A. Brinton;David P. Byar;Donald K. Corle.
Journal of the National Cancer Institute (1989)

3789 Citations

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff.
The Lancet (1997)

3561 Citations

Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates.
The Lancet (1996)

1723 Citations

ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA

Paolo Bruzzi;Sylvan B. Green;David P. Byar;Louise A. Brinton.
American Journal of Epidemiology (1985)

1702 Citations

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Catherine Schairer;Jay Lubin;Rebecca Troisi;Susan Sturgeon.
JAMA (2000)

1504 Citations

Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

N Hamajima;K Hirose;K Tajima;T Rohan.
British Journal of Cancer (2002)

1086 Citations

Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status

Celia Byrne;Catherine Schairer;John Wolfe;Navin Parekh.
Journal of the National Cancer Institute (1995)

1062 Citations

Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults

Steven C. Moore;I-Min Lee;Elisabete Weiderpass;Peter T. Campbell.
JAMA Internal Medicine (2016)

1055 Citations

The risk of breast cancer after estrogen and estrogen-progestin replacement.

LElF Bergkvist;Hans-Olgy Adami;Ingemar Persson;Robert Hoover.
The New England Journal of Medicine (1989)

890 Citations

Menopausal hormone replacement therapy and risk of ovarian cancer.

James V. Lacey;Pamela J. Mink;Jay H. Lubin;Mark E. Sherman.
JAMA (2002)

844 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Catherine Schairer

Susan E. Hankinson

Susan E. Hankinson

University of Massachusetts Amherst

Publications: 220

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 186

Graham A. Colditz

Graham A. Colditz

Washington University in St. Louis

Publications: 169

Carlo La Vecchia

Carlo La Vecchia

University of Milan

Publications: 161

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 154

Louise A. Brinton

Louise A. Brinton

National Institutes of Health

Publications: 131

Bernard Rosner

Bernard Rosner

Harvard University

Publications: 120

Rulla M. Tamimi

Rulla M. Tamimi

Cornell University

Publications: 118

Giske Ursin

Giske Ursin

University of Oslo

Publications: 114

David J. Hunter

David J. Hunter

University of Oxford

Publications: 110

Shelley S. Tworoger

Shelley S. Tworoger

Harvard University

Publications: 109

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 107

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 107

Elisabete Weiderpass

Elisabete Weiderpass

International Agency For Research On Cancer

Publications: 105

Hans-Olov Adami

Hans-Olov Adami

Karolinska Institutet

Publications: 102

Petra H.M. Peeters

Petra H.M. Peeters

Utrecht University

Publications: 101

Trending Scientists

Jesper Møller

Jesper Møller

Aalborg University

Carlos G. Puntonet

Carlos G. Puntonet

University of Granada

Bennett B. Goldberg

Bennett B. Goldberg

Northwestern University

Hans-Hermann Thulke

Hans-Hermann Thulke

Helmholtz Centre for Environmental Research

Marta Barral

Marta Barral

Instituto de Salud Carlos III

Christian S. Hardtke

Christian S. Hardtke

University of Lausanne

David L. Nelson

David L. Nelson

Baylor College of Medicine

Philippe Büscher

Philippe Büscher

Institute of Tropical Medicine Antwerp

William H. Farrand

William H. Farrand

Space Science Institute

Marco Raugei

Marco Raugei

Oxford Brookes University

Xuebin Zhang

Xuebin Zhang

Environment and Climate Change Canada

Rebecca F. Gottesman

Rebecca F. Gottesman

Johns Hopkins University

Ruth Boaden

Ruth Boaden

University of Manchester

Ilan Salomon

Ilan Salomon

Hebrew University of Jerusalem

John B. Cullen

John B. Cullen

Washington State University

Chris Evans

Chris Evans

UK Astronomy Technology Centre

Something went wrong. Please try again later.